Engineering the microflora to vaccinate the mucosa: Serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

Immunology

Volumn 100, Issue 4, 2000, Pages 510-518

  Shaw, D M ^a   Gaerthe B ^a   Leer, R J ^a   Van Der Stap, J G M M ^a   Smittenaar, C ^a   Heijne Den Bak Glashouwer, M J ^a   Thole, J E R ^a   Tielen, F J ^a   Pouwels, P H ^a   Havenith, C E G ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; SECRETORY IMMUNOGLOBULIN; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BIOMEDICAL ENGINEERING; CELL SURFACE; CERVICAL LYMPH NODE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE DEFICIENCY; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LUNG LAVAGE; LYMPH NODE; MICROFLORA; MOLECULAR WEIGHT; MOUSE; MOUTH MUCOSA; MUCOSA; NONHUMAN; NOSE MUCOSA; PEDIATRICS; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN G; LACTOBACILLUS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; TETANUS TOXIN; VACCINES, DNA;

EID: 0033858446     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00069.x     Document Type: Article

References (23)

1. 1. Walker R.I. (1994) New strategies for using mucosal vaccination to achieve more effective immunisation. Vaccine 12, 387.
2. 2. Curtiss R. (1990) Attenuated Salmonella strains as live vectors for the expression of foreign antigens. In: New Generation Vaccines (eds G. C. Woodrow & M. M. Levine), p. 347. Marcel Dekker Inc, New York.
3. 3. Stover C.K., de la Crus V.F., Fuerst T.R. et al. (1991) New use of BCG for recombinant vaccines. Nature 351, 456.
4. 4. Butterton J.R., Boyko S.A. & Calderwood S.B. (1993) Use of the Vibrio cholerae IgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains. Vaccine 11, 1327.
5. 5. Wells J.M., Robinson K., Chamberlain L.M. et al. (1996) Lactic acid bacteria as vaccine delivery vehicles. In: Lactic Acid Bacteria: Genetics, Metabolism and Applications (eds G. Venema, J. H. J. Huis in't Veld & J. Hugenholtz), p. 221-234. Kluwer Academic Publishers, Dordrecht.
6. 6. Hone D.M., Harris A.M., Chatfield S., Dougan G. & Levine M.M. (1991) Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9, 810.
7. 7. Pouwels P.H., Leer R.J. & Boersma W.J.A. (1996) The potential of Lactobacillus as a carrier for oral immunisation. Development and preliminary characterisation of vector systems for targeted delivery of antigens. J Biotechnol 44, 183.
8. 8. Claassen E., Kottenhagen M.J., Pouwels P.H. et al. (1994) Use of Lactobacillus, a GRAS (generally recognised as safe) organism as a base for a new generation of oral live vaccines. In: Recombinant and Synthetic Vaccines (eds S. Talwar et al.), p. 407-412. Narosa Publishing House, New Delhi.
9. 9. Marcotte H. & Lavoie M.C. (1996) No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice. Infect Immun 64, 4694.
10. 10. Fernandez C.F., Shahani K.M. & Amer M.A. (1987) Therapeutic role of dietary lactobacilli and lactobacilli fermented dairy products. FEMS Microbiol Rev 46, 343.
11. 11. Perdignon G., de Macias M.E., Alvarez S., Oliver G. & de Ruiz Holgado A.P. (1988) Systemic augmentation of the immune response in mice by feeding fermented milk with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63, 17.
12. 12. Isolauri E., Joensuu J., Suomalainen H., Luomala M. & Vesikari T. (1995) Improved immunogenicity of oral D × RRV reassortment rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310.
13. 13. Gerritse K., Posno M., Schellekens M.M., Boersma W.J.A. & Claassen E. (1990) Oral administration of TNP-Lactobacillus conjugates in mice. A model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli. Res Microbiol 141, 955.
14. 14. Rangavajhyala K.M., Shahani G. & Srikumaran S. (1997) Non-lipopolysaccharide components of Lactobacillus acidophilus stimulates the production of IL-1 and TNF-β by murine macrophages. Nutr Cancer 28, 130.
15. 15. Suda Y., Tochio H., Kawano K. et al. (1995) Cytokine-inducing glycolipids in the lipoteichoic acid fraction from Enterococcus hirae ATCC 9790. FEMS Immun Med Microbiol 12, 97.
16. 16. Medaglini D., Pozzi G., King T.P. & Fishetti V.A. (1995) Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonisation. Proc Natl Acad Sci USA 92, 6868.
17. 17. Samuelson P., Hansson M., Ahlborg N. et al. (1995) Cell-surface display of recombinant proteins on Staphylococcus carnosus. J Bacteriol 177, 1470.
18. 18. Maassen C.B., Laman J.D., den Bak-Glashouwer M.J. et al. (1999) Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine 17, 2117.
19. 19. Partidos C.D. & Steward M.W. (1990) Prediction and identification of a T-cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J Gen Virol 71, 2099.
20. 20. Czerkinsky C.C., Nilsson L.-A., Nygren H., Ouchterlony O. & Tarkowski A. (1983) A. solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65, 109.
21. 21. Robinson K., Chamberlain L.M., Schofield K.M., Wells J.M. & Le Page R.W.F. (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nature Biotechnol 15, 653.
22. 22. Wu H.-Y., Nikolova E.B., Beagley K.W., Eldridge J.H. & Russel M.W. (1997) Development of antibody-secreting cells and antigen specific T-cells in cervical lymph nodes after intranasal immunisation. Infect Immun 65, 227.
23. 23. Stanfeild J.P. & Galazka A. (1994) Neonatal tetanus in the world today. Bull WHO 62, 647.